Editas Medicine

Biotechnology

Editas Medicine is developing CRISPR-based gene editing therapies for serious diseases, including genetic eye diseases and sickle cell disease. The company was founded by pioneers of CRISPR technology and focuses on both in vivo and ex vivo editing approaches. Editas is advancing the clinical application of precise genome editing.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me